| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
33,721 |
30,828 |
$2.97M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14,220 |
14,160 |
$1.26M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,844 |
3,615 |
$351K |
| 71046 |
Radiologic examination, chest; 2 views |
4,720 |
4,544 |
$223K |
| 99215 |
Prolong outpt/office vis |
1,952 |
1,926 |
$174K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,744 |
1,732 |
$149K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
1,395 |
1,259 |
$136K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
516 |
476 |
$84K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
12,730 |
11,952 |
$59K |
| 99205 |
Prolong outpt/office vis |
585 |
583 |
$53K |
| 93000 |
|
3,044 |
2,991 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,813 |
5,604 |
$10K |
| 73562 |
|
237 |
236 |
$5K |
| 73630 |
|
168 |
163 |
$3K |
| H0033 |
Oral medication administration, direct observation |
3,258 |
3,207 |
$3K |
| 82962 |
|
4,608 |
4,322 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
911 |
855 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,228 |
2,142 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
17 |
16 |
$2K |
| 81003 |
|
10,283 |
9,907 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
607 |
581 |
$1K |
| 73610 |
|
53 |
53 |
$1K |
| 81025 |
|
6,357 |
6,131 |
$960.13 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
866 |
847 |
$847.15 |
| 72100 |
|
30 |
30 |
$781.56 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
493 |
471 |
$569.29 |
| 73130 |
|
25 |
24 |
$502.55 |
| 73030 |
|
12 |
12 |
$232.74 |
| 85018 |
|
239 |
237 |
$148.58 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
14 |
14 |
$120.80 |
| 73140 |
|
12 |
12 |
$109.13 |
| 96373 |
|
16 |
16 |
$82.08 |
| 90714 |
|
31 |
31 |
$60.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
16 |
16 |
$46.35 |
| 99000 |
|
273 |
261 |
$23.63 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
27 |
27 |
$8.88 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
41 |
41 |
$7.44 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
165 |
163 |
$0.75 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
130 |
124 |
$0.40 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
53 |
29 |
$0.00 |
| 69209 |
|
15 |
14 |
$0.00 |
| A9150 |
Non-prescription drugs |
110 |
103 |
$0.00 |
| 94760 |
|
12 |
12 |
$0.00 |